# SRT Therapeutics, Inc. — Form D

SRT Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-14. The offering totals $47.5M, of which $47.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-08-14
- Form: D
- Accession: 0002080322-25-000008
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $47.5M
- Amount sold: $47.4M
- Remaining: $111K
- Investors: 55
- Date of first sale: 2025-04-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-554665

## Issuer

- Name: SRT Therapeutics, Inc.
- CIK: 0002080322
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 5601 Oberlin Drive, Suite 100, San Diego, CA, 92121
- Phone: (858) 868-7108

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Rolf Benirschke | Director | San Diego, CA |
| Brian G Feagan, M.D. | Director | San Diego, CA |
| Lauren Otsuki | Director | San Diego, CA |
| Ed Prunchunas | Director | San Diego, CA |
| Michael Walsh | Director | New York, NY |
| Shierley Widjaja | Director | San Diego, CA |
| Lauren Otsuki | Executive Officer | San Diego, CA |

## More

- [CIK 2080322 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2080322&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002080322-25-000008.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.